Caffeine and Resistance Training in Young Adults
Effects of Acute and Prolonged Caffeine Intake on Neuromuscular Adaptations to Resistance Training in Young Adults
1 other identifier
interventional
48
1 country
1
Brief Summary
Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine intake on sports performance, specifically on strength and power performance. However, little is known about the prolonged effect of this supplement on neuromuscular adaptations to strength training. Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine intake on sports performance, specifically on strength and power performance. However, little is known about the prolonged effects of this supplement on neuromuscular adaptations to strength training. Objectives: The present study aims to analyze the effects of acute and chronic caffeine intake on neuromuscular adaptations to strength training, according to sex (men vs. women) and type of exercise (bench press vs. squat), as well as on fatigue resistance during repeated sprints, fatigue perception, mood state, reaction time, diet, and potential side effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2024
CompletedFirst Submitted
Initial submission to the registry
September 9, 2024
CompletedFirst Posted
Study publicly available on registry
September 24, 2024
CompletedSeptember 24, 2024
September 1, 2024
1.4 years
September 9, 2024
September 19, 2024
Conditions
Outcome Measures
Primary Outcomes (7)
Mean velocity at different %1RM
Measuring bar mean velocity desplacement during bench press and back squat exercises.
Through study completion, an average of 12 weeks
Peak velocity at different %1RM
Measuring bar peak velocity and time to reach peak velocity of bar desplacement during bench press and back squat exercises.
Through study completion, an average of 12 weeks
Mean power output at different %1RM
Measuring during bench press and back squat exercises.
Through study completion, an average of 12 weeks
Peak power output and time to reach peak power output at different %1RM
Measuring during bench press and back squat exercises.
Through study completion, an average of 12 weeks
Number of repetitions performed at 65%1RM until task failure
In bench press and back squat exercises
Through study completion, an average of 12 weeks
Bar velocity deplacement performed in 1 set at 65%1RM until task failure
In bench press and back squat exercises
Through study completion, an average of 12 weeks
Power output generated in 1 set at 65%1RM until task failure
In bench press and back squat exercise
Through study completion, an average of 12 weeks
Secondary Outcomes (8)
Resting Metabolic Rate (RMR)
Through study completion, an average of 12 weeks
Maximal Fat Oxidation Rate (MFO)
Through study completion, an average of 12 weeks
Fat mass
Through study completion, an average of 12 weeks
Fat-free mass
Through study completion, an average of 12 weeks
Physical activity (METs-min/wk)
Through study completion, an average of 12 weeks
- +3 more secondary outcomes
Study Arms (4)
Caffeine - Males
EXPERIMENTALPlacebo - Males
PLACEBO COMPARATORCaffeine - Females
EXPERIMENTALPlacebo - Females
PLACEBO COMPARATORInterventions
Acute caffeine intake (3 mg/kg) prior each resistance training session of a 8 weeks training program.
Acute placebo intake (3 mg/kg of maltodextrin) prior each resistance training session of a 8 weeks training program.
Eligibility Criteria
You may qualify if:
- Age between ≥ 18 and ≤ 35 years.
- Body mass index (BMI) \< 25 kg/m².
- Physically active subjects (\>150 min/week of moderate exercise).
- Healthy men and women without neurological, cardiometabolic, immunological, or physical conditions that prevent them from performing physical exercise.
- Participants capable of performing the tests.
You may not qualify if:
- History of neuromuscular, cardiac, or diseases that could affect liver or muscle metabolism.
- Use of drugs or other stimulants that interfere with caffeine intake and intestinal absorption during the tests and study.
- Body mass index (BMI) \> 25 kg/m².
- Having undergone prolonged periods of forced physical inactivity during the 6 months prior to the study.
- Performing strenuous exercise within 48 hours prior to the tests.
- Failing to replicate the same food intake on the two experimental days.
- Consuming caffeine after 6 PM on the day prior to training or testing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá
Alcalá de Henares, Madrid, 28805, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Statistician
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 9, 2024
First Posted
September 24, 2024
Study Start
January 15, 2023
Primary Completion
May 30, 2024
Study Completion
May 30, 2024
Last Updated
September 24, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share